The Prevalence of Hepatitis E in a Patient Cohort Presenting With Addictive Injection Behavior
Introduction: Hepatitis E is the most common cause of acute viral hepatitis worldwide. Seroprevalence is approximately 15% in developed countries, and 22% in France. hepatitis E virus (HEV) can be transmitted via transfusions and therefore possibly intravenous (IV) drug use. Hepatitis E serology is...
Main Authors: | Antoine Yrondi, Juliette Salles, Jean Marie Péron, Marie Sporer, Simon Taib, Adeline Gallini, Chloé Noilhan, Chloé Dimeglio, Flora Entajan, Marie Crequy, Jacques Izopet, Laurent Schmitt |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fpsyt.2019.00832/full |
Similar Items
-
Developing and Testing a Local Expert-Based Reading Process for Use to Examine Discrepancies Between Guidelines and Current Clinical Practices
by: Cécile Cases, et al.
Published: (2021-03-01) -
HEPATIC SINUSOIDAL MACROPHAGES (KUPFER'S AND ENDOTHELIAL CELLS) IN THE HEROIN ADDICTS
by: Jovan Stajanovic, et al.
Published: (2000-09-01) -
Analyses of Clinical and Biological Data for French and Belgian Immunocompetent Patients Infected With Hepatitis E Virus Genotypes 4 and 3
by: Florence Micas, et al.
Published: (2021-04-01) -
Hepatitis E prevalence in French Polynesian blood donors.
by: Chloé Dimeglio, et al.
Published: (2018-01-01) -
The real seroprevalence of SARS-CoV-2 in France and its consequences for virus dynamics
by: Chloé Dimeglio, et al.
Published: (2021-06-01)